π©Ί UK-SPECIFIC ORGAN-SPECIFIC INFECTIONS & TREATMENT GUIDELINES π₯
Based on NICE (NG250 for pneumonia, NG109/113 for UTI, NG141 for SSTI, NG240 for meningitis, NG199 for C. diff), BASHH for STIs, BSAC for endocarditis, and other UK sources like PHE/UKHSA. Always consult local guidelines, BNF, and specialists. Dates reflect latest updates as of 2025.
-
1. RESPIRATORY TRACT INFECTIONS π¬οΈ
-
1.1 Community-Acquired Pneumonia (CAP) π«
- Most Common Pathogens:
- π’ S. pneumoniae (mainstay)
- π£ Mycoplasma pneumoniae, Legionella, C. pneumoniae (atypicals)
- π H. influenzae (esp. in COPD)
- Assessment: Use CRB-65 score (NICE NG250). Score 0-1: Outpatient; 2: Hospital; β₯3: Urgent hospital.
- Treatment (NICE NG250):
- πΆββοΈ Low severity (outpatient): Amoxicillin 500mg TDS x 5 days (first-line). If atypical suspected or penicillin allergy: Doxycycline 200mg day 1, then 100mg OD x 4 days OR Clarithromycin 500mg BD x 5 days.
- π₯ High severity (hospital, non-ICU): Co-amoxiclav 1g TDS IV/PO + Clarithromycin 500mg BD. Switch to oral when stable.
- π Severe/ICU: Co-amoxiclav + Clarithromycin + consider adding Levofloxacin if Legionella risk. Add Corticosteroids (e.g., hydrocortisone) for high-severity.
- Duration: 5 days; extend if not improving.
-
1.2 Hospital-Acquired Pneumonia (HAP) ποΈ
- Pathogens: Gram-negatives (Pseudomonas), MRSA.
- Treatment (NICE NG139): Pip/taz 4.5g TDS IV OR Cefuroxime 1.5g TDS + Metronidazole if anaerobic risk. Add MRSA cover if needed (Vancomycin). Start within 1-4 hours.
-
1.3 Pharyngitis/Tonsillitis π€
- Group A Strep (Centor score β₯3): Phenoxymethylpenicillin (Pen V) 500mg QDS x 10 days (NICE). Allergy: Clarithromycin 250mg BD x 5 days.
2. URINARY TRACT INFECTIONS (UTI) π½
2.1 Uncomplicated Lower UTI (Cystitis) π§
- #1 Pathogen: π£ E. coli.
- Treatment (NICE NG109): Non-pregnant women: Nitrofurantoin 100mg BD x 3 days (first-line). Alternatives: Trimethoprim 200mg BD x 3 days (if resistance <20%). Pregnant women: Nitrofurantoin x 7 days (avoid 3rd trimester). Men: x 7 days.
- Delay if mild: Back-up prescription with self-care advice.
2.2 Acute Pyelonephritis π©Έ
- Treatment (NICE NG109): Ciprofloxacin 500mg BD x 7 days (avoid if resistance high; MHRA warnings). Alternatives: Co-amoxiclav 500/125mg TDS x 7-10 days OR Cefalexin 500mg QDS x 7-10 days.
2.3 Catheter-Associated UTI π©Ή
- Treatment (NICE NG113): Only treat symptomatic. Ciprofloxacin 500mg BD x 7 days OR Co-amoxiclav. Remove/replace catheter.
-
3. SKIN & SOFT TISSUE INFECTIONS π©Ή
-
3.1 Cellulitis/Erysipelas π‘
- Pathogens: π‘ S. aureus, π΄ S. pyogenes.
- Treatment (NICE NG141): Flucloxacillin 500mg QDS x 5-7 days (PO). Severe: IV 1-2g QDS. Allergy: Clarithromycin 500mg BD OR Clindamycin 300mg QDS.
- MRSA risk: Clindamycin or Doxycycline.
-
3.2 Abscess/Boil π©Έ
- I&D primary. Antibiotics if systemic symptoms: Flucloxacillin + Clindamycin for MRSA cover.
-
3.3 Necrotizing Fasciitis β οΈ
- Treatment: Urgent surgery + Clindamycin 600-900mg IV TDS (toxin suppression) + broad-spectrum (e.g., Pip/taz 4.5g TDS).
-
4. CENTRAL NERVOUS SYSTEM π§
-
4.1 Bacterial Meningitis (Age-Based) π
- Empiric (NICE NG240/UK JSSG): Give IV antibiotics ASAP (within 1 hour if sepsis). Ceftriaxone 2g BD (adults) + Dexamethasone 10mg IV QDS (before/with first dose, if pneumococcal suspected).
- Neonates: Cefotaxime + Ampicillin (Listeria cover).
- Children/Young Adults: Ceftriaxone (meningococcus/pneumococcus).
- Adults >50/Elderly: Add Ampicillin 2g QDS for Listeria.
- Duration: 7-14 days depending on organism.
-
4.2 Brain Abscess π©Έ
- Treatment: Ceftriaxone 2g BD + Metronidazole 400mg TDS + consider Flucloxacillin. Surgery if needed.
-
5. GASTROINTESTINAL INFECTIONS π€’
-
5.1 Bacterial Diarrhea π¦
| Pathogen | Treatment (NICE/PHE) |
| π£ Salmonella (non-typhi) | Supportive (avoid abx unless severe) |
| π£ Shigella | Ciprofloxacin 500mg BD x 3 days |
| π€ C. difficile | Vancomycin 125mg QDS PO x 10 days (first-line, NICE NG199). Severe/recurrent: Fidaxomicin 200mg BD x 10 days. Stop offending abx. |
| π£ Campylobacter | Supportive; Azithromycin if severe |
5.2 Intra-abdominal Infections π«
- Treatment: Pip/taz 4.5g TDS IV OR Ceftriaxone 2g OD + Metronidazole 400mg TDS.
-
6. SEXUALLY TRANSMITTED INFECTIONS π
| Disease | Pathogen | Treatment (BASHH 2023/2024) |
| π¦ Gonorrhoea | N. gonorrhoeae | Ceftriaxone 1g IM single dose + Azithromycin 2g PO single dose (or Doxycycline 100mg BD x 7d if macrolide allergy) |
| π΄ Chlamydia | C. trachomatis | Doxycycline 100mg BD x 7 days (first-line) OR Azithromycin 1g single dose |
| π£ Syphilis | T. pallidum | Benzathine penicillin 2.4g IM (early); 3 doses weekly (late). Alternative: Doxycycline 100mg BD x 14/28 days |
| π¦ Trichomoniasis | T. vaginalis | Metronidazole 400mg BD x 5-7 days OR 2g single dose |
7. BONE & JOINT INFECTIONS π¦΄
7.1 Osteomyelitis π¦΄
- Empiric: Flucloxacillin 1-2g QDS IV (S. aureus cover). Add Clindamycin if MRSA.
- Duration: 4-6 weeks total (IV 1-2 weeks, then oral switch if stable, per BSAC/BOA).
- Children: Early OPAT consideration (BOAST).
-
7.2 Septic Arthritis π§
- Treatment: Urgent aspiration/drainage + Flucloxacillin IV. Gonococcal: Ceftriaxone.
- Duration: 2-4 weeks IV/PO.
8. ENDOCARDITIS β€οΈ
| Organism | Treatment (BSAC/BNF) | Duration |
| π’ Viridians Strep (sensitive) | Benzylpenicillin 1.8g QDS IV | 4 weeks |
| π΄ S. aureus (MSSA) | Flucloxacillin 2g QDS IV | 4-6 weeks |
| π‘ S. aureus (MRSA) | Vancomycin IV (trough 10-20mg/L) | 4-6 weeks |
| β« Enterococcus | Ampicillin 2g QDS + Gentamicin 1mg/kg TDS | 4-6 weeks |
| π£ HACEK | Ceftriaxone 2g BD IV | 4 weeks |
Empiric: Vancomycin + Gentamicin + Flucloxacillin or Piperacillin/tazobactam.
9. HIGH-YIELD EMERGENCY ANTIBIOTICS π―
- Neutropenic Fever: Pip/taz 4.5g TDS IV (or Ceftazidime).
- Meningitis (empiric): Ceftriaxone 2g BD IV + Dexamethasone.
- Sepsis (empiric): Pip/taz + Gentamicin (NICE sepsis bundle).
- Bite wounds: Co-amoxiclav 500/125mg TDS x 5 days (NICE NG184).
- Catheters: Vancomycin + remove device.
10. RESISTANCE PATTERNS β οΈ
- MRSA: Vancomycin, Daptomycin, Linezolid.
- VRE: Linezolid, Daptomycin.
- ESBL: Carbapenems (e.g., Ertapenem).
- Pseudomonas: Dual therapy e.g., Ceftazidime + Ciprofloxacin.
**π©Ί KEY TAKEAWAYS FOR UK EXAMS (PLAB/MRCP):**
- **NICE emphasis: Antimicrobial stewardship, short courses, local resistance data.
- **MRSA/Pseudomonas: Risk assess (hospitalisation, ICU).
- **Sepsis: Within 1 hour antibiotics (NICE NG51).
- **Prophylaxis: No routine for IE (NICE CG64); focus on hygiene.
- **Always: Source control + de-escalate based on cultures. Consult BNF for doses.